We therefore followed the frequencies and MFI (expression) of the ectonucleotidases CD39 and CD73 and of the NAD-degrading enzyme cyclic ADP ribose hydrolase (CD38) on live B cells cultured from HC and ME/CFS patients (Figure 2). This evidence concerns the gene NT5E and myalgic encephalomeyelitis/chronic fatigue syndrome.